Highlight HEALTH 2.0

Researchers at the University of Liverpool in the U.K. have developed a method of 3D visualization for the conducting pathways of the heart.

Researchers at the University of Pittsburg have reported using a new imaging technique called High-Definition Fiber Tracking (HDFT) to identify the disrupted neural pathways (paths made up of brain cells that communicate with one another) in patients with traumatic brain injury.

Neoprobe's newly licensed radiopharmaceutical imaging agent, AZD4694, is a fluorine-18 labeled radioligand for use in the imaging and evaluation of patients with signs or symptoms of cognitive impairment such as Alzheimer's disease.